Skip to content

Ketamine: all studies

Page 311 of 448: studies 3,101 to 3,110 of 4,475, newest first. Back to the ketamine overview

Research

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

Biological Psychiatry October 1, 2000 Lawrence S. Kegeles, Anissa Abi‐dargham, Y. Zea‐Ponce et al.

BACKGROUND Recent brain imaging studies have indicated that schizophrenia is associated with increased amphetamine-induced dopamine release in the striatum. It has long been hypothesized that dysregulation of subcortical dopamine systems in schizophrenia might result from a failure of the prefrontal cortex (PFC) to adequately control subcortical dopaminergic function. The activity of midbrain...

Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.

Journal of Pharmacology and Experimental Therapeutics April 1, 2000 G. Duncan, S. Miyamoto, Jeremy N Leipzig et al.

The ability of subanesthetic doses of N-methyl-D-aspartate (NMDA) antagonists to induce positive, negative, and cognitive schizophrenia-like symptoms suggests that reduced NMDA receptor function may contribute to the pathophysiology of schizophrenia. An increasing body of evidence indicates that antipsychotic drugs, especially those with "atypical" properties, can antagonize the effects of NMDA...

Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients

Pain April 1, 2000 Thomas Graven‐nielsen, Sally Kendall, Karl G. Henriksson et al. 409 citations

Central mechanisms related to referred muscle pain and temporal summation of muscular nociceptive activity are facilitated in fibromyalgia syndrome (FMS) patients. The present study assessed the effects of an NMDA-antagonist (ketamine) on these central mechanisms. FMS patients received either i.v. placebo or ketamine (0.3 mg/kg, Ketalar((R))50% decrease in pain intensity at rest by active drug...

DOI: 10.1016/s0304-3959(99)00308-5 (opens in new tab) Ketamine Hypertonic saline Anesthesia Fibromyalgia +6

Attenuation of the Neuropsychiatric Effects of Ketamine With Lamotrigine

Archives of General Psychiatry March 1, 2000 Amit Anand, Dennis S. Charney, Dan A. Oren et al. 425 citations

BACKGROUND: The cognitive, behavioral, and mood effects of N-methyl-D-aspartate (NMDA) receptor antagonists, such as phencyclidine and ketamine, have been used to study the effects of NMDA receptor dysfunction. Pharmacological modulation of the effects of NMDA receptor antagonists, such as ketamine, may lead to development of novel therapeutic agents for psychiatric illnesses such as...

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions.

Biological Psychiatry January 15, 2000 J. Krystal, A. Bennett, D. Abi‐Saab et al.

BACKGROUND The demands of the Wisconsin Card Sorting Test (WCST) change with experience. This report contains two studies designed to examine N-methyl-D-aspartate (NMDA) receptor contributions to the executive components of WCST performance. These aspects of WCST performance figure more prominently in the initial completion of this task than in subsequent task repetitions in healthy...

Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primates.

Psychopharmacology September 1, 1999 Y Shiigi, D E Casey

The dopamine hypothesis is the most widely investigated theory underlying schizophrenia and the mechanisms of action for antipsychotic drugs. However, recent studies call into question this proposal. Thus, the focus has turned towards other mechanisms, one of which has been glutamatergic systems. Phencyclidine (PCP), a potent NMDA receptor antagonist, causes a schizophrenic-like psychosis in...

Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes

Pain August 1, 1999 Roger Schmid, Alan N. Sandler, Joel Katz 547 citations

Ketamine hydrochloride is a well known general anesthetic and short acting analgesic in use for almost 3 decades. The role of the NMDA receptor in the processing of nociceptive input has led naturally to renewed clinical interest in N-methyl-D-aspartate (NMDA) receptor antagonists such as ketamine. This paper reviews the use and efficacy of low-dose ketamine in the management of acute...

DOI: 10.1016/s0304-3959(99)00044-5 (opens in new tab) Analgesic Anesthesia Nmda receptor Adverse effect +7

Ketamine

Anesthesia & Analgesia November 1, 1998 Rainer Kohrs, Marcel E. Durieux 610 citations

Ketamine has a special position among anesthetic drugs. It was introduced into clinical practice >30 yr ago with the hope that it would function as a "monoanesthetic" drug: inducing analgesia, amnesia, loss of consciousness, and immobility. This dream was not fulfilled because significant side effects were soon reported. With the introduction of other IV anesthetic drugs, ketamine's role...

Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions

The Quarterly journal of medicine July 1, 1998 Ian G. Mills 92 citations

We have previously shown that eating disorders are a compulsive behaviour disease, characterized by frequent recall of anorexic thoughts. Evidence suggests that memory is a neocortical neuronal network, excitation of which involves the hippocampus, with recall occurring by re-excitement of the same specific network. Excitement of the hippocampus by glutamate-NMDA receptors, leading to long-term...

Psychedelic Effects of Ketamine in Healthy Volunteers

Anesthesiology 1998 Andrew t. Bowdle, Allen d. Radant, Deborah s. Cowley et al. 371 citations

Background Ketamine has been associated with a unique spectrum of subjective "psychedelic" effects in patients emerging from anesthesia. This study quantified these effects of ketamine and related them to steady-state plasma concentrations. Methods Ketamine or saline was administered in a single-blinded crossover protocol to 10 psychiatrically healthy volunteers using computer-assisted...

DOI: 10.1097/00000542-199801000-00015 (opens in new tab) Ketamine ketamine levels Ketamine concentrations Potent psychedelic compounds Dose-response relationship direct +9